| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | helicase activity | 5.10e-05 | 158 | 51 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.51e-04 | 614 | 51 | 8 | GO:0140657 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.09e-04 | 127 | 51 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 4.15e-04 | 12 | 51 | 2 | GO:0015279 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 5.71e-04 | 14 | 51 | 2 | GO:0070679 | |
| GeneOntologyBiologicalProcess | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 7.34e-06 | 16 | 50 | 3 | GO:1902166 | |
| GeneOntologyBiologicalProcess | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1.48e-05 | 20 | 50 | 3 | GO:1902165 | |
| GeneOntologyBiologicalProcess | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 4.21e-05 | 28 | 50 | 3 | GO:1902254 | |
| GeneOntologyBiologicalProcess | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 6.33e-05 | 32 | 50 | 3 | GO:1902230 | |
| GeneOntologyBiologicalProcess | negative regulation of signal transduction by p53 class mediator | 1.34e-04 | 41 | 50 | 3 | GO:1901797 | |
| GeneOntologyBiologicalProcess | regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 1.44e-04 | 42 | 50 | 3 | GO:1902253 | |
| GeneOntologyBiologicalProcess | regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 1.66e-04 | 44 | 50 | 3 | GO:1902229 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway in response to DNA damage | 1.85e-04 | 117 | 50 | 4 | GO:0008630 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.28e-04 | 49 | 50 | 3 | GO:0042771 | |
| GeneOntologyBiologicalProcess | spleen development | 2.72e-04 | 52 | 50 | 3 | GO:0048536 | |
| Domain | TRP_dom | 1.09e-04 | 6 | 51 | 2 | IPR013555 | |
| Domain | TRP_2 | 1.09e-04 | 6 | 51 | 2 | PF08344 | |
| Domain | TRPC_channel | 1.52e-04 | 7 | 51 | 2 | IPR002153 | |
| Domain | Helicase_C | 2.07e-04 | 107 | 51 | 4 | PF00271 | |
| Domain | HELICc | 2.07e-04 | 107 | 51 | 4 | SM00490 | |
| Domain | Helicase_C | 2.14e-04 | 108 | 51 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 2.22e-04 | 109 | 51 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.22e-04 | 109 | 51 | 4 | PS51192 | |
| Domain | DEXDc | 2.22e-04 | 109 | 51 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.30e-04 | 110 | 51 | 4 | IPR014001 | |
| Domain | HTH_MYB | 2.60e-04 | 9 | 51 | 2 | PS51294 | |
| Domain | Myb_dom | 2.60e-04 | 9 | 51 | 2 | IPR017930 | |
| Domain | TRP_channel | 3.96e-04 | 11 | 51 | 2 | IPR004729 | |
| Domain | P-loop_NTPase | 4.29e-04 | 848 | 51 | 9 | IPR027417 | |
| Domain | SNF2_N | 3.44e-03 | 32 | 51 | 2 | IPR000330 | |
| Domain | SNF2_N | 3.44e-03 | 32 | 51 | 2 | PF00176 | |
| Domain | - | 3.95e-03 | 746 | 51 | 7 | 3.40.50.300 | |
| Domain | Myb_DNA-binding | 4.11e-03 | 35 | 51 | 2 | PF00249 | |
| Domain | DEAH_ATP_HELICASE | 4.83e-03 | 38 | 51 | 2 | PS00690 | |
| Domain | MYB_LIKE | 4.83e-03 | 38 | 51 | 2 | PS50090 | |
| Domain | Kinesin_motor_CS | 5.60e-03 | 41 | 51 | 2 | IPR019821 | |
| Domain | Kinesin-like_fam | 6.15e-03 | 43 | 51 | 2 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 6.43e-03 | 44 | 51 | 2 | PS00411 | |
| Domain | - | 6.43e-03 | 44 | 51 | 2 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 6.43e-03 | 44 | 51 | 2 | IPR001752 | |
| Domain | Kinesin | 6.43e-03 | 44 | 51 | 2 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 6.43e-03 | 44 | 51 | 2 | PS50067 | |
| Domain | KISc | 6.43e-03 | 44 | 51 | 2 | SM00129 | |
| Domain | ZnF_C3H1 | 7.61e-03 | 48 | 51 | 2 | SM00356 | |
| Domain | zf-CCCH | 7.92e-03 | 49 | 51 | 2 | PF00642 | |
| Pubmed | 5.16e-07 | 486 | 51 | 8 | 20936779 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31996681 | ||
| Pubmed | Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. | 2.11e-06 | 2 | 51 | 2 | 9930701 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 22724068 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 30599775 | ||
| Pubmed | A novel fusion gene CRTC3-MAML2 in hidradenoma: histopathological significance. | 2.11e-06 | 2 | 51 | 2 | 29079171 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 24453217 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 32140760 | ||
| Pubmed | [Mechanism of cardiac hypertrophy via diacylglycerol-sensitive TRPC channels]. | 2.11e-06 | 2 | 51 | 2 | 20190513 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 25213992 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 27861908 | ||
| Pubmed | Structure of the receptor-activated human TRPC6 and TRPC3 ion channels. | 2.11e-06 | 2 | 51 | 2 | 29700422 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 18608209 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 23800468 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 28105583 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 35051376 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 22306362 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 19749484 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 9368034 | ||
| Pubmed | Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma. | 2.11e-06 | 2 | 51 | 2 | 19749740 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 18050304 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 33333171 | ||
| Pubmed | A TRPC3/6 Channel Inhibitor Promotes Arteriogenesis after Hind-Limb Ischemia. | 2.11e-06 | 2 | 51 | 2 | 35805125 | |
| Pubmed | N-linked protein glycosylation is a major determinant for basal TRPC3 and TRPC6 channel activity. | 2.11e-06 | 2 | 51 | 2 | 12970363 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 37762093 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 24905090 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 28790356 | ||
| Pubmed | Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma. | 6.32e-06 | 3 | 51 | 2 | 12893366 | |
| Pubmed | Selective association of TRPC channel subunits in rat brain synaptosomes. | 6.32e-06 | 3 | 51 | 2 | 12377790 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 32097940 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 27402217 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 27979597 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 28526717 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 24425872 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 36569761 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 23938296 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 21668476 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 26930718 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 10611319 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 19052171 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 24121173 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15358862 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 21757714 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 30138216 | ||
| Pubmed | Orai proteins interact with TRPC channels and confer responsiveness to store depletion. | 6.32e-06 | 3 | 51 | 2 | 17360584 | |
| Pubmed | Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma. | 6.32e-06 | 3 | 51 | 2 | 28438292 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 19074769 | ||
| Pubmed | Involvement of Rab9 and Rab11 in the intracellular trafficking of TRPC6. | 6.32e-06 | 3 | 51 | 2 | 20346379 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 20728215 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 19260825 | ||
| Pubmed | A new nucleoporin-like protein interacts with both HIV-1 Rev nuclear export signal and CRM-1. | 1.26e-05 | 4 | 51 | 2 | 10358091 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 12356946 | ||
| Pubmed | The role of cGMP/cGKI signalling and Trpc channels in regulation of vascular tone. | 1.26e-05 | 4 | 51 | 2 | 23832809 | |
| Pubmed | The contribution of TRPC1, TRPC3, TRPC5 and TRPC6 to touch and hearing. | 1.26e-05 | 4 | 51 | 2 | 26520460 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 30017393 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 22566504 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 28636132 | ||
| Pubmed | 1.72e-05 | 34 | 51 | 3 | 24026423 | ||
| Pubmed | Formation of novel TRPC channels by complex subunit interactions in embryonic brain. | 2.10e-05 | 5 | 51 | 2 | 12857742 | |
| Pubmed | TRPC channels are necessary mediators of pathologic cardiac hypertrophy. | 2.10e-05 | 5 | 51 | 2 | 20351294 | |
| Pubmed | Enhanced capacitative calcium entry and TRPC channel gene expression in human LES smooth muscle. | 2.10e-05 | 5 | 51 | 2 | 12736151 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 21261756 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 30452936 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 22027011 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 24449818 | ||
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 18436303 | ||
| Pubmed | TRPC3 channels are required for synaptic transmission and motor coordination. | 2.10e-05 | 5 | 51 | 2 | 18701065 | |
| Pubmed | DMTF1 MASTL MARCHF7 NFKBIZ CEP295 ARHGEF3 CPLANE1 NUP153 KIF2C | 2.52e-05 | 1084 | 51 | 9 | 11544199 | |
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 11390792 | ||
| Pubmed | trp, a novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry. | 3.15e-05 | 6 | 51 | 2 | 8646775 | |
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 25347706 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 32414784 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 3.39e-05 | 861 | 51 | 8 | 36931259 | |
| Pubmed | A common variant in DRD3 receptor is associated with autism spectrum disorder. | 3.83e-05 | 128 | 51 | 4 | 19058789 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 3.88e-05 | 430 | 51 | 6 | 35044719 | |
| Pubmed | MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPC. | 4.41e-05 | 7 | 51 | 2 | 15757897 | |
| Pubmed | Mechanism of stretch-induced activation of the mechanotransducer zyxin in vascular cells. | 4.41e-05 | 7 | 51 | 2 | 23233529 | |
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 32350291 | ||
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 36592529 | ||
| Pubmed | Functional role of TRPC proteins in vivo: lessons from TRPC-deficient mouse models. | 4.41e-05 | 7 | 51 | 2 | 15336983 | |
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 38835669 | ||
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 1347918 | ||
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 36257322 | ||
| Pubmed | Subunit composition of mammalian transient receptor potential channels in living cells. | 5.87e-05 | 8 | 51 | 2 | 12032305 | |
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 25471572 | ||
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 15199065 | ||
| Pubmed | Characterization of GATA-1(+) hemangioblastic cells in the mouse embryo. | 7.54e-05 | 9 | 51 | 2 | 17159898 | |
| Pubmed | Homer binds TRPC family channels and is required for gating of TRPC1 by IP3 receptors. | 7.54e-05 | 9 | 51 | 2 | 14505576 | |
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 11290752 | ||
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 17480026 | ||
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 15623527 | ||
| Pubmed | Heterogeneous distribution of TRPC proteins in the embryonic cortex. | 9.42e-05 | 10 | 51 | 2 | 18989690 | |
| Pubmed | 9.42e-05 | 10 | 51 | 2 | 27177420 | ||
| Pubmed | 1.63e-04 | 13 | 51 | 2 | 21318276 | ||
| Pubmed | 1.63e-04 | 13 | 51 | 2 | 22051675 | ||
| Pubmed | 1.90e-04 | 14 | 51 | 2 | 18528438 | ||
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | 2.01e-04 | 77 | 51 | 3 | 24927568 | |
| Pubmed | The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. | 2.19e-04 | 15 | 51 | 2 | 15107403 | |
| Pubmed | 2.83e-04 | 17 | 51 | 2 | 22411552 | ||
| Pubmed | Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains. | 3.55e-04 | 19 | 51 | 2 | 14578343 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | DMTF1 DENND4A ST7 CD44 ANO1 MASTL HELZ CHD9 MAML2 NUP42 ARHGEF3 RGS12 | 5.67e-08 | 843 | 51 | 12 | M2356 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | DENND4A ERCC6L2 MASTL HELZ HFM1 MAEL CEP295 CPLANE1 KIF24 KIF2C | 1.76e-05 | 820 | 50 | 10 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.42e-08 | 142 | 51 | 6 | e160f35b3c18e77c4107fe96db5f56227c91785e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-06 | 157 | 51 | 5 | f6210be2362d833c6d869ff921188bfc85dda11d | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.00e-06 | 157 | 51 | 5 | 43a6b423fd70479822a564ff4225a1e4951ae5ed | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-06 | 169 | 51 | 5 | 41ad349806b279fbe1374b7e3cc7f146a11adb44 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-06 | 169 | 51 | 5 | 42782c61592742190ab0cba8a94f8bdf9c278f90 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 3.21e-06 | 199 | 51 | 5 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Sigmoid-(5)_Dendritic_cell-(50)_cDC2|Sigmoid / shred on region, Cell_type, and subtype | 3.21e-06 | 199 | 51 | 5 | 402af84db90d8a49d67cf44c24766aefb00fd716 | |
| ToppCell | Sigmoid-Dendritic_cell-cDC2|Sigmoid / Region, Cell class and subclass | 3.21e-06 | 199 | 51 | 5 | cd74db6db694b68f81dcf9d9342d125d00357ec1 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.14e-05 | 157 | 51 | 4 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.38e-05 | 160 | 51 | 4 | 6ed37d1fd0304932319d6b942502404115ff36a7 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.46e-05 | 161 | 51 | 4 | d72c572613f8eff3251cb7b1e9dcc76d193b2f21 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-3|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 3.46e-05 | 161 | 51 | 4 | 52239a887799362256ecd7e740b716b88ed59a62 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.69e-05 | 174 | 51 | 4 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.79e-05 | 175 | 51 | 4 | cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.79e-05 | 175 | 51 | 4 | a8400e7e47379901dcab5f2e364c3ff17765b4b9 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-05 | 175 | 51 | 4 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.79e-05 | 175 | 51 | 4 | 8a3abf40146ae3459d97cdf865c1c8f6b92ac639 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.79e-05 | 175 | 51 | 4 | 378d2b79edac91fc74eee0fb42bb29dd9b07c36f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.01e-05 | 177 | 51 | 4 | 84116796ca4c7007508c0f1a68a1135c7b922278 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.46e-05 | 181 | 51 | 4 | 062f00736eed96e4f4327615d093558dd7d82b20 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.82e-05 | 184 | 51 | 4 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.82e-05 | 184 | 51 | 4 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | P28-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.07e-05 | 186 | 51 | 4 | a38f84f478798951c8798c8e90e4897c729cf630 | |
| ToppCell | P28-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.07e-05 | 186 | 51 | 4 | 375642f353842184792a834361284d6897c728de | |
| ToppCell | P28-Endothelial-unknown_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.07e-05 | 186 | 51 | 4 | dde38decf368775694bbeae38a3ff084017c34ab | |
| ToppCell | P15-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.20e-05 | 187 | 51 | 4 | 60f41b1f1b656d211b80398aa2cf0ac0cdad9372 | |
| ToppCell | P15-Endothelial-unknown_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.20e-05 | 187 | 51 | 4 | d543ddc63f864b6d0982c4ff652af174af085c4a | |
| ToppCell | P15-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.33e-05 | 188 | 51 | 4 | c0a03e33027f52b5c25ffbc8f822128e5160ed20 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.59e-05 | 190 | 51 | 4 | 52213cd2a6a20772d4f49ba9ac0407abafa528db | |
| ToppCell | P07-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.59e-05 | 190 | 51 | 4 | 5d25e40bc2cca314f4265e4001a546e6d99e2a79 | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.59e-05 | 190 | 51 | 4 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.59e-05 | 190 | 51 | 4 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.59e-05 | 190 | 51 | 4 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.59e-05 | 190 | 51 | 4 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.73e-05 | 191 | 51 | 4 | 718330bb97fe8a1ffd0c82e9af23311a32eacfe1 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.73e-05 | 191 | 51 | 4 | 454034ad940377ee079afa8ce33f8e0bdeaf44f8 | |
| ToppCell | Endothelial-B|World / shred on cell class and cell subclass (v4) | 6.73e-05 | 191 | 51 | 4 | 8b7857dee69d0ba3e59e230c9fd372e14695299e | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.87e-05 | 192 | 51 | 4 | 53d438e35c14e7656585942b788459e6d843c555 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.87e-05 | 192 | 51 | 4 | 9a1aeac3ecf31f865a23d8ee15a82aef31779089 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.87e-05 | 192 | 51 | 4 | 2360824910cd471c8286ca369ba144d90d984602 | |
| ToppCell | Endothelial-Endothelial-B|Endothelial / shred on cell class and cell subclass (v4) | 6.87e-05 | 192 | 51 | 4 | f8d7bd81e031d09a557722627c2f6180811cc6ab | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-05 | 193 | 51 | 4 | ac1073bf4d3868841226b850b058f1e27326a14e | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.15e-05 | 194 | 51 | 4 | fc40ab57be3a15c043e3414c2c678c1dc52207c8 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.15e-05 | 194 | 51 | 4 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.15e-05 | 194 | 51 | 4 | 50fa7c7940b113427c87fbdb9057fef8e1ce52c5 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 7.15e-05 | 194 | 51 | 4 | 4547b57669be5d4f0de55175802ee04372288a6a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.15e-05 | 194 | 51 | 4 | 8deeb3e00237e3d9ad5a1457cd0061576421b9e9 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD56bright_CD16-|lymph-node_spleen / Manually curated celltypes from each tissue | 7.15e-05 | 194 | 51 | 4 | 8a596f25f6bfa5baaa2f52d80ad92f2925713398 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.15e-05 | 194 | 51 | 4 | b81801fb16e8bd0d6083fe32866051d3c60f3dc7 | |
| ToppCell | BAL-Control|BAL / Compartment, Disease Groups and Clusters | 7.29e-05 | 195 | 51 | 4 | bf940d836a34118a56bc956e6210e310510bca4d | |
| ToppCell | distal-Hematologic-Basophil/Mast_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.29e-05 | 195 | 51 | 4 | 4f83449fce3717518e2acbba1a4b3bea765c0bdb | |
| ToppCell | critical-Epithelial-FOXN4+|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.73e-05 | 198 | 51 | 4 | 6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.04e-05 | 200 | 51 | 4 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.04e-05 | 200 | 51 | 4 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.04e-05 | 200 | 51 | 4 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.04e-05 | 200 | 51 | 4 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.04e-05 | 200 | 51 | 4 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 8.04e-05 | 200 | 51 | 4 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.04e-05 | 200 | 51 | 4 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| Disease | Inherited acute myeloid leukemia | 1.75e-05 | 4 | 51 | 2 | C4707228 | |
| Disease | arf-GAP domain and FG repeat-containing protein 1 measurement | 1.75e-05 | 4 | 51 | 2 | EFO_0803312 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.91e-04 | 12 | 51 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | ulcerative colitis | 2.80e-04 | 335 | 51 | 5 | EFO_0000729 | |
| Disease | peritonsillar abscess | 4.40e-04 | 18 | 51 | 2 | EFO_0007429 | |
| Disease | colorectal cancer | 5.91e-04 | 604 | 51 | 6 | MONDO_0005575 | |
| Disease | calcium measurement | 7.25e-04 | 628 | 51 | 6 | EFO_0004838 | |
| Disease | lifestyle measurement | 7.31e-04 | 235 | 51 | 4 | EFO_0010724 | |
| Disease | gallstones | 8.74e-04 | 108 | 51 | 3 | EFO_0004210 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 9.27e-04 | 26 | 51 | 2 | C0009405 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 1.15e-03 | 29 | 51 | 2 | C1333990 | |
| Disease | platelet crit | 1.20e-03 | 952 | 51 | 7 | EFO_0007985 | |
| Disease | Spinocerebellar Ataxia Type 2 | 1.59e-03 | 34 | 51 | 2 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 1.59e-03 | 34 | 51 | 2 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 1.59e-03 | 34 | 51 | 2 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 1.59e-03 | 34 | 51 | 2 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 1.59e-03 | 34 | 51 | 2 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 1.59e-03 | 34 | 51 | 2 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 1.68e-03 | 35 | 51 | 2 | C0752122 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSQSQTHSLQANDTF | 421 | Q9NR81 | |
| NDSSQEEHQDFLQFS | 16 | O00574 | |
| EADEATNYNSHNSQS | 476 | Q155Q3 | |
| NAVAFRSFNSHINAS | 651 | Q96GX5 | |
| HLSNRSTDSQNSFAS | 221 | P28566 | |
| ENNFTLTDNHDNTAN | 521 | P33151 | |
| SFNDAHVSKFSDQNS | 626 | Q9Y222 | |
| VTSSFNASNTNIFQN | 1426 | Q7Z401 | |
| TFSVDDSQSFQNLSN | 86 | P51151 | |
| AQHNSFSGFSSSDNV | 466 | Q52LD8 | |
| SSVQQQNDAHLHSFS | 361 | Q9BYH8 | |
| FSHFNSSNEEQRSNT | 356 | Q96JY0 | |
| SFHISNLQFNSSLED | 1046 | P15941 | |
| NTLENSEDSFFLHQT | 846 | Q5T7B8 | |
| FSAFSENNESSNNPS | 181 | Q92887 | |
| LQFIDSFLNTSSNHE | 396 | P10242 | |
| SFLNTSSNHENSDLE | 401 | P10242 | |
| VNHTLSSFNVSDFQN | 831 | Q5XXA6 | |
| ELQDHSNQSSFNFSS | 1786 | P42694 | |
| NNSSSDNAQNFSFKT | 236 | O15504 | |
| TTASSQENHSSQTDN | 336 | Q9BPV8 | |
| SANVFTANNAFSASE | 216 | A2PYH4 | |
| DHSSDLAFDFLSQQN | 1101 | Q8IZL2 | |
| NHTNQTLSDFTGSNS | 296 | Q3L8U1 | |
| QQSNSQSFSTSHEGL | 506 | P16070 | |
| QQFTFQDSNNSVDSS | 376 | Q9H799 | |
| AGDSLTFHNNQSFST | 231 | Q15485 | |
| TFHNNQSFSTKDQDN | 236 | Q15485 | |
| SSASEFQPSFHQADN | 71 | Q6UUV7 | |
| VTSFASNLHTDNLNA | 631 | O75128 | |
| SHNHSSESDSENFNQ | 361 | Q9H992 | |
| FNSSSVNEFAKHITN | 1246 | Q5T890 | |
| DNCHFQESTELNNTF | 106 | Q9H4G1 | |
| FHFSQKTQENTSSEQ | 1271 | Q9C0D2 | |
| TFANSNSSRSHACFQ | 461 | Q99661 | |
| SLNFSQSAHSASEQQ | 366 | P35716 | |
| ASASNRFSNDSQLHD | 286 | Q9Y4L5 | |
| HFCQTNSVQTDLFSS | 1221 | Q14191 | |
| NLSAQDHQTFFTCDS | 166 | Q9NRC1 | |
| NQEHSQSFTFDDAQQ | 26 | Q9NPQ8 | |
| FSNTHFFKDENNSSL | 136 | Q8IZF4 | |
| HFNSHAAQNSANADF | 226 | P52594 | |
| QQEFDQTFQSHFISD | 206 | Q15846 | |
| SFLSDSDFHNSKQFS | 16 | Q8IXP5 | |
| NHFEETNSSSQNSSE | 376 | Q5T7W0 | |
| DAHQNNSTSSNSDSG | 411 | O14924 | |
| ADQTHAQNFSSAVKS | 196 | Q5SNT2 | |
| QFGSSTTNFNFTNNS | 1396 | P49790 | |
| FSDLSSFDLHQQLQS | 261 | Q9NYT6 | |
| NSSSESFGHNLTVNF | 171 | Q8N0Z9 | |
| SIRSSEDFHLNSFNN | 836 | Q9Y210 | |
| QENAVKDFTSFSTHN | 156 | Q6N021 | |
| SNFNSAHDTDQNLSV | 296 | O95932 | |
| TQSNSRVFESHSFNS | 741 | Q13507 |